Fausto R. Loberiza - Concepedia

Author

Fausto R. Loberiza

Also Known As

F Loberiza, F R Loberiza, F. Loberiza, F. R. Loberiza, F. R. Loberiza Jr., F.R. Loberiza, FAUSTO R. LOBERIZA, Fausto Loberiza, Fausto R Loberiza, Fausto R. Loberiza

218

Publications

Citations

H-Index

118

Concepts

All Affiliations

University of Nebraska Medical Center Medical College of Wisconsin Fred Hutch Cancer Center The University of Texas MD Anderson Cancer Center Dana-Farber Cancer Institute

About

Fausto R. Loberiza is an author at University of Nebraska Medical Center specializing in medicine, transplantation, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	40	2.5K
2	Health Sciences	15	16	754
3	Public Health	12	12	719
4	Nursing	1	1	29
5	Social Sciences	1	1	138

Fausto R. Loberiza

Publications

8.7K

Citations

H-Index

Page 1

	Year	Citations
Cotransplantation of HLA-Identical Sibling Culture-Expanded Mesenchymal Stem Cells and Hematopoietic Stem Cells in Hematologic Malignancy Patients Hillard M. Lazarus, Omer N. Koç, Steven M. Devine, Biology of Blood and Marrow Transplantation	2005	792
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study Mary Eapen, Pablo Rubinstein, Mei-Jie Zhang, The Lancet Acute LeukaemiaTransplantationMarrow TransplantationPediatric HematologyStem Cell Transplantation	2007	791
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Richard E. Champlin, Norbert Schmitz, Mary M. Horowitz, PubMed	2000	508
A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model Xu Zhang, Fausto R. Loberiza, John P. Klein, Computer Methods and Programs in Biomedicine Sas MacroPrognosisSurvival CurvesBiostatisticsPublic Health	2007	279
HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome Yogen Saunthararajah, Ryotaro Nakamura, Jun-Mo Nam, Blood	2002	269
Higher Mortality After Allogeneic Peripheral-Blood Transplantation Compared With Bone Marrow in Children and Adolescents: The Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry Mary Eapen, Mary M. Horowitz, John P. Klein, Journal of Clinical Oncology	2004	261
Flow-Induced Dilation of Human Coronary Arterioles Hiroto Miura, Ruth E. Wachtel, Yan-Ping Liu, Circulation	2001	249
Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of Unrelated Donors Theresa Hahn, Philip L. McCarthy, Anna Hassebroek, Journal of Clinical Oncology	2013	243
Association of Depressive Syndrome and Early Deaths Among Patients After Stem-Cell Transplantation for Malignant Diseases Fausto R. Loberiza, J. Douglas Rizzo, Christopher Bredeson, Journal of Clinical Oncology	2002	210
Health‐related quality of life in children with sickle cell disease: child and parent perception Julie A. Panepinto, Kerry M. O’Mahar, Michael R. DeBaun, British Journal of Haematology	2005	189

Page 1